SCHEMBL29930809

SCHEMBL29930809

C[Si](C)(C)CCOCn1nc(-c2ccc(O)cc2)c2cc(Br)cnc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 4/20 0.37
DYRK1A Q13627 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
ESR1 P03372 7/20 0.34
ESR2 Q92731 1/20 0.33
MERTK Q12866 2/20 0.32
AURKA O14965 1/20 0.32
RET P07949 1/20 0.32
SRC P12931 1/20 0.32
AXL P30530 1/20 0.32
KDR P35968 1/20 0.32
FLT3 P36888 1/20 0.32
NPC1 O15118 1/20 0.31
MAPT P10636 2/20 0.31
MET P08581 1/20 0.31
PRKAB2 O43741 1/20 0.30
PRKAG1 P54619 1/20 0.30
PRKAA2 P54646 1/20 0.30
PRKAA1 Q13131 1/20 0.30
PRKAG3 Q9UGI9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1592834 0.90 MERTK (0.39) DGAT1DYRK1ADYRK1BMERTKAURKA
SCHEMBL29930779 0.88 AXL (0.41) DGAT1DYRK1ADYRK1BMERTKAURKA
SCHEMBL29930508 0.87 DGAT1 (0.36) DGAT1DYRK1ADYRK1BMERTKMAPT
SCHEMBL29930721 0.86 MERTK (0.42) DGAT1MERTKNPC1MAPTALDH1A1
SCHEMBL29930712 0.85 DYRK1A (0.38) DGAT1DYRK1ADYRK1BESR1MERTK
SCHEMBL29930707 0.85 DYRK1A (0.45) DYRK1ADYRK1B
SCHEMBL29930401 0.85 DYRK1B (0.40) DGAT1DYRK1BMERTKAURKARET
SCHEMBL29930775 0.85 MAPT (0.35) DGAT1NPC1MAPTALDH1A1MAPK1
SCHEMBL29930917 0.84 DYRK1B (0.38) DGAT1DYRK1BMERTKKDR
SCHEMBL29930904 0.84 CLK1 (0.39) DGAT1DYRK1ADYRK1BESR1MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed